Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Newswire Search Past 90 Days 6 stories 2 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View
Related Topics
Topic # Mentions Topic Reach
Prominent Journalists
Byline Articles Written Avg Reach
by PR Newswire 5 -
TajSabreen Ahamed 1 -


Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
by PR Newswire — thailand-business-news.com


Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
by PR Newswire — thailand-business-news.com


Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
by PR Newswire — thailand-business-news.com


Antengene Secures $60 Million Upfront In UCB Licensing Deal
TajSabreen Ahamed — rttnews.com


Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB
by PR Newswire — thailand-business-news.com


Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
by PR Newswire — thailand-business-news.com

Execution: 1.35 Seconds. 61.1 mb used.